Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel for prevention of post-stroke seizures
ACTRN12618001984280Phase 2Completed
- Sponsor
- Alfred Health
- Start
- Aug 2019
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in stroke and seizure comparing Perampanel with Placebo (2 arms). Primary endpoint: Proportion of patients seizure free during observation phase. Started Aug 2019; status: completed.
02
Drugs
perampanel
03
Conditions
strokeseizure
Beyond the preview
Go deeper on ACTRN12618001984280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001984280.